J. Melville Engle

2012

In 2012, J. Melville Engle earned a total compensation of $906K as Former Chief Executive Officer at Cesca Therapeutics, a 57% increase compared to previous year.

Compensation breakdown

Bonus$125,000
Salary$246,000
Stock Awards$198,000
Other$337,000
Total$906,000

Engle received $337K in other compensation, accounting for 37% of the total pay in 2012.

Engle also received $125K in bonus, $246K in salary and $198K in stock awards.

Rankings

In 2012, J. Melville Engle's compensation ranked 6,525th out of 11,487 executives tracked by ExecPay. In other words, Engle earned more than 43.2% of executives.

ClassificationRankingPercentile
All
6,525
out of 11,487
43rd
Division
Manufacturing
2,336
out of 4,253
45th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
294
out of 624
53rd
Industry group
Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
94
out of 189
50th
Industry
Laboratory Apparatus and Furniture
1
out of 12
92nd
Source: SEC filing on October 23, 2012.

Engle's colleagues

We found four more compensation records of executives who worked with J. Melville Engle at Cesca Therapeutics in 2012.

2012

Matthew Plavan

Cesca Therapeutics

Chief Executive Officer

2012

Hal Baker

Cesca Therapeutics

Former V.P., Commercial Operations & Marketing

2012

Ken Pappa

Cesca Therapeutics

V.P., Manufacturing and IT

2012

Kevin Cooksy

Cesca Therapeutics

V.P., Corporate Development & Scientific Affairs

You may also like